Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Pharmacology|April 29, 1998
Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectivesN R Cutler, J J Sramek, D J Greenblatt, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.
The American Journal of Cardiology|June 1, 1995
Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectorisN R Cutler, R J Anders, S S Jhee, et al.
Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.
Neurology|August 1, 1995
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptanA M Rapoport, W H Visser, N R Cutler, et al.
Neurology|July 1, 1986
Positron emission tomography in Alzheimer's diseaseR Duara, C Grady, J Haxby, et al.
Annals of Neurology|December 1, 1984
Human brain glucose utilization and cognitive function in relation to ageR Duara, C Grady, J Haxby, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Apomorphine response and subtyping of schizophreniaD V Jeste, S Zalcman, D R Weinberger, et al.
Annals of Neurology|September 1, 1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseN R Cutler, J V Haxby, R Duara, et al.
Clinical Neuropharmacology|August 1, 1995
Pramipexole in patients with early Parkinson's diseaseJ P Hubble, W C Koller, N R Cutler, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Pharmacology|April 29, 1998
Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectivesN R Cutler, J J Sramek, D J Greenblatt, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.
The American Journal of Cardiology|June 1, 1995
Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectorisN R Cutler, R J Anders, S S Jhee, et al.
Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.
Neurology|August 1, 1995
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptanA M Rapoport, W H Visser, N R Cutler, et al.
Neurology|July 1, 1986
Positron emission tomography in Alzheimer's diseaseR Duara, C Grady, J Haxby, et al.
Annals of Neurology|December 1, 1984
Human brain glucose utilization and cognitive function in relation to ageR Duara, C Grady, J Haxby, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Apomorphine response and subtyping of schizophreniaD V Jeste, S Zalcman, D R Weinberger, et al.
Annals of Neurology|September 1, 1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseN R Cutler, J V Haxby, R Duara, et al.
Clinical Neuropharmacology|August 1, 1995
Pramipexole in patients with early Parkinson's diseaseJ P Hubble, W C Koller, N R Cutler, et al.
Pageof 17